These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8029510)

  • 1. Serum and pleural fluid levels of CA50 in malignant and tuberculous effusions.
    Yang SZ; Ji SQ
    Respir Med; 1994 Jan; 88(1):27-9. PubMed ID: 8029510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].
    Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of pleural effusions].
    Ogino M; Koike K; Satoh K; Arai K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoembryonic antigen assay in serum and pleural effusion of pulmonary malignancies and benign lesions].
    Jiang XF; Zhu YJ; Zhao WL; Ma X; Lo WC
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):430-1. PubMed ID: 3582109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in pleural effusions in bronchogenic carcinoma and tuberculosis].
    Plavec G; Ninković M; Kozlovacki G; Lazarov A; Tatić V
    Vojnosanit Pregl; 2002; 59(1):23-8. PubMed ID: 11928185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of CEA assay combined with CA50 in malignant and benign effusion].
    Xu WB
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):327-9, 384. PubMed ID: 3250750
    [No Abstract]   [Full Text] [Related]  

  • 10. The ovarian cancer associated antigen CA 125 in patients with pleural effusions.
    Lindgren J; Kuusela P; Hellström PE; Pettersson T; Klockars M
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):737-9. PubMed ID: 3164270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
    Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
    Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-16 in tuberculous and malignant pleural effusions.
    Qin XJ; Shi HZ; Huang ZX; Kang LF; Mo WN; Wu C
    Eur Respir J; 2005 Apr; 25(4):605-11. PubMed ID: 15802332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
    Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orosomucoid, alpha 2-macroglobulin and immunoglobulins in serum and pleural effusions.
    Asseo PP; Tracopoulos GD
    Am J Clin Pathol; 1981 Oct; 76(4):437-41. PubMed ID: 7293967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
    Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
    J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion].
    Tomita Y
    Igaku Kenkyu; 1989 Nov; 59(3):90-6. PubMed ID: 2639592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
    Paluch E; Ioachim HL
    J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.